Amine Compounds Having Anti-Inflammatory, Antifungal, Antiparasitic, and Anticancer Activity
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2014/013992, filed Jan 31, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,030,015 | Amine Compounds Having Anti-Inflammatory, Antifungal, Antiparasitic, and Anticancer Activity In force · High confidence | Pharma Cinq, LLC | In force | High confidence | ||
| US 10,934,284 | Aminoquinazoline Compounds Having Anti-Inflammatory, Antifungal, Antiparasitic, and Anticancer Activity In force · Medium confidence | Pharma Cinq, LLC | In force | Medium confidence | ||
| US 12,139,483 | Imidazoquinolyl Compounds Having Anti-Inflammatory, Antifungal, Antiparasitic, and Anticancer Activity In force · Medium confidence | Pharma Cinq, LLC | In force | Medium confidence | ||
| Application 16/015,264 | Aminoquinoline Compounds Having Anticancer Activity Abandoned Abandoned Mar 11, 2019 | Pharma Cinq, LLC | Abandoned | Abandoned Mar 11, 2019 | not computed | |
| Application 18/906,289 | Amine Compounds Having Anti-Inflammatory, Antifungal, Antiparasitic, and Anticancer Activity Pending Not granted | Pharma Cinq, LLC | Pending | Not granted | not computed |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Pharma Cinq, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.